Clinical features of molecular pathology of solid tumours in childhood
Authors:
- Ruth NashRNRuth Nash
- Iona JeffreyIJIona Jeffrey
- Kathy Pritchard-JonesKPKathy Pritchard-Jones
- Sandra HingSHSandra Hing
- 1 June 2005
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 6 (6) , 421-430
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Gene Expression Signatures Identify Rhabdomyosarcoma Subtypes and Detect a Novel t(2;2)(q35;p23) Translocation Fusing PAX3 to NCOA1Cancer Research, 2004
- Genomic approaches to hematologic malignanciesBlood, 2004
- GermlineTP53 mutations and Li-Fraumeni syndromeHuman Mutation, 2003
- Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networksNature Medicine, 2001
- A Multiplex Real-Time PCR Assay for the Detection of Gene Fusions Observed in Solid TumorsLaboratory Investigation, 2001
- Ewing Sarcoma vs Lymphoblastic LymphomaAmerican Journal of Clinical Pathology, 2001
- Mutation analysis of p53 gene in childhood malignant solid tumorsJournal of Pediatric Surgery, 1997
- THE GENETICS OF WILMS’ TUMOR—A Case of Disrupted DevelopmentAnnual Review of Genetics, 1994
- A comparative study of immunohistochemical staining for neuron‐specific enolase, protein gene product 9.5 and S‐100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumours in childrenHistopathology, 1990
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971